Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Hormone therapy using
leuprolide and flutamide may fight prostate cancer by reducing the production of androgens.
Combining radiation therapy with hormone therapy may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of hormone therapy plus radiation therapy
in treating patients with prostate cancer.